Neuronal molecular mimicry in immune-mediated neurologic disease

Annals of Neurology

Volumn 44, Issue 1, 1998, Pages 87-98

  Levin, Michael C ^a,c   Krichavsky, Marc ^a   Berk, Jeff ^b   Foley, Shanon ^a   Rosenfeld, Myrna ^b   Dalmau, Josep ^b   Chang, Greg ^a   Posner, Jerome B ^b   Jacobson, Steven ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; HUMAN TISSUE; IMMUNE MEDIATED INJURY; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SPASTIC PARAPLEGIA;

AUTOIMMUNE DISEASES; BLOTTING, WESTERN; BRAIN CHEMISTRY; CELLS, CULTURED; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LEUKEMIA, T-CELL; MOLECULAR MIMICRY; NEURONS; PARAPARESIS, TROPICAL SPASTIC; PARKINSON DISEASE; REFERENCE VALUES;

EID: 0031878667     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440115     Document Type: Article

References (43)

1. Martin R, Hohlfeld R, McFarland H. Infections and inflammatory diseases: multiple sclerosis. In: Brandt T, Caplan LR, Dichgans J, eds. Neurological disorders: course and treatment. New York: Academic Press, 1996:483-505
2. Martin R, McFarland H. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995;32:121-182
3. Levin M, Jacobson S. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol 1997;3:126-140
4. Jacobson S, Levin M, Utz U, Drew P. Infectious immune disorders: HTLV. In: Antel J, Birnbaum G, Hartung H, eds. Clinical neuroimmunology. Cambridge: Blackwell Science, 1998;204-217
5. Mattson D, McFarlin D, Mora C, Zaninovic V. Central nervous system lesions detected by magnetic resonance imaging in an HTLV-1 antibody positive symptomless individual. Lancet 1987;2:29 (Letter)
6. Moore G, Traugott U, Scheinberg L, Raine C. Tropical spastic paraparesis: a model of virus-induced cytotoxic T cell-mediated demyelination? Ann Neurol 1989;26:523-530
7. Hollsberg P, Hafler D. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993; 328:1173-1182
8. Nakagawa M, Izumo S, Ijichi S, et al. HTLV-1 associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1995;1:50-61
9. Levin M, Lehky T, Flerlage N, et al. Immunopathogenesis of HTLV-1 associated neurologic disease based on a spinal cord biopsy from a patient with HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP). N Engl J Med 1997; 336:839-845
10. Yoshioka A, Hirose G, Ueda Y, et al. Neuropathological studies of the spinal cord in early stage HTLV-1 associated myelopathy (HAM). J Neurol Neurosurg Psychiatry 1993;56:1004-1007
11. Umehara F, Izumo S, Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrates in the spinal cord lesions in HTLV-1 associated myelopathy. J Neuropathol Exp Neurol 1993;52:424-430
12. Umehara F, Nakamura A, Izumo S, et al. Apoptosis of T lymphocytes in the spinal cord lesions of HTLV-I associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol 1994; 53:617-624
13. Kubota R, Umehara F, Izumo S, et al. HTLV-1 proviral DNA correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-1 associated myelopathy. J Neuroimmunol 1994;53:23-29
14. Kira J, Itohama Y, Koyanagi Y, et al. Presence of HTLV-1 proviral DNA in central nervous system of patients with HTLV-1 associated myelopathy. Ann Neurol 1992;31:39-45
15. + T lymphocytes. Ann Neurol 1996;40: 84-90
16. Lehky T, Fox C, Koenig S, et al. Detection of human T lymphotropic virus type I (HTLV-1) tax RNA in the central nervous system of HTLB-1 associated myelopathy/tropical spastic paraparesis by in situ hybridization. Ann Neurol 1995;37:246-254
17. Jacobson S, Shida H, McFarlin D, et al. Circulating CD8+ cytotoxic lymphocytes specific for HTLV-1 in patients with HTLV-1 associated neurological disease. Nature 1990;348: 245-248
18. Jacobson S, McFarlin D, Robinson S, et al. Demonstration of HTLV-i specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-1 associated neurologic disease. Ann Neurol 1992;32:651-657
19. Gessain A, Vernant J, Maurs L, et al. Antibodies to human T-lymphotropic virus I in patients with tropical spastic paraparesis. Lancet 1985;2:407-410
20. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy: a new clinical entity. Lancet 1986;1:1031-1032
21. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann Neurol 1987;21:117-122
22. Ceroni M, Piccardo P, Rodgers-Johnson P, et al. Intrathecal synthesis of IgG antibodies to HTLV-1 supports an etiological role for HTLV-1 in tropical spastic paraparesis. Ann Neurol 1988;23:188-191
23. Kitze B, Puccioni-Sohler M, Schaffner J, et al. Specificity of intrathecal IgG synthesis for HTLV-1 cor and envelope proteins in HAM/TSP. Acta Neurol Scand 1995;92:213-217
24. Saarloos M, Koenig R, Spear G. Elevated levels of iC3b and C4d, but not Bb, complement fragments from plasma of persons infected with human T-cell leukemia virus (HTLV) with HTLV-I associated myelopathy/tropical spastic paraparesis. J Infect Dis 1995;172:1095-1097
25. Kira J, Koyanagi Y, Yamada T, et al. Increased HTLV-I proviral DNA in HTLV-I associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 1991;29:194-201
26. Dalmau J, Furneaux H, Gralla R, et al. Detection of the anti-hu antibody in the serum of patients with small cell lung cancer - a quantitative western blot analysis. Ann Neurol 1990; 27:544-552
27. Drew P, Lonergan M, Goldstein M, et al. Regulation of MHC class I and b2-microglobulin gene expression in human neuronal cells. J Immunol 1993;150:3300-3310
28. Levin M, Fox R, Lehky T, et al. Polymetase chain reaction/in situ hybridization detection of HTLV-I tax proviral DNA in peripheral blood lymphocytes of patients with HTLV-1 associated neurologic disease. J Virol 1996;70:924-933
29. Szabo A, Dalmau J, Manley G, et al. HuD a paraneoplastic enchephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal. Cell 1991;67:325-333
30. Clemens K, Piras G, Radonovich M, et al. Interaction of the human T-cell lymphotropic virus type I tax transactivator with transcription factor IIA. Mol Cell Biol 1996;16:4656-4664
31. Jean W, Dalmau J, Ho A, Posner J. Analysis of the IgG sub-class distribution and inflammatory infiltrates in patients with ant-Hu associated paraneoplastic encephalomyelitis. Neurology 1994;44:140-147
32. Posner J. Neurologic complications of cancer. In: Contemporary neurology series. Philadelphia: FA Davis, 1995:372-373
33. Barnett L, Fujinami R. Molecular mimicry: a mechanism for autoimmune injury. FASEB J 1992;6:840-844
34. Evans C, Horowitz M, Hobbs M, Oldstone M. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 1996;184:2371-2384
35. Oldstone M. Molecular mimicry and autoimmune disease. Cell 1987;50:819-820
36. Schwimmbeck P, Dyrberg T, Drachman D, Oldstone M. Molecular mimicry and myasthenia gravis. J Clin Invest 1989;84: 1174-1180
37. Oldstone M, von Herrath M, Evans C, Horowitz MS. Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. Curr Top Microbiol Immunol 1996;206:67-83
38. Srinivasappa J, Saegusa J, Prabhakar B, et al. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 1986;57:397-401
39. Moore G, Traugott U, Scheinberg L, Raine C. Tropical spastic paraparesis: a model of virus induced, cytotoxic T cell-mediated demyelination? Ann Neurol 1989;26:523-530
40. Palker T, Scearce R, Ho W, et al. Monoclonal antibodies reactive with human T cell lymphotropic virus I (HTLV-I) p19 internal core protein: cross reactivity with normal tissues and differential reactivity with HTLV types I and II. J Immunol 1985;135:247-254
41. Lucchinetti C, Rodriguez M. The controversy surrounding the pathogenesis of the multiple sclerosis lesion. Mayo Clin Proc 1997;72:665-678
42. Wiley R. Targeting toxins to neural antigens and receptors. Semin Cancer Biol 1996;7:71-77
43. Suzuki J, Kira J, Baba E, et al. The association of antibodies against human T cell lymphotropic virus type I (HTLV) pX gene mutant products with HTLV-I-associated myelopathy/ tropicals spastic paraparesis. J Infect Dis 1996;173:1115-1122